Chan Liu

Chan Liu

Auto-generated profile, based on publicly available information

Chan Liu

Clinical pharmacy, Liuyang People's Hospital, No. 452, Daowushan West Road, Liuyang, Hunan, 410300, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in FEMS Microbiology Letters
Verified
Journal Article
Closed access
YSYoulu Su
Youlu Su
CLChan Liu
Chan Liu
YDYiqin Deng
Yiqin Deng
CCChanghong Cheng
Changhong Cheng
HMHongling Ma
Hongling Ma
JFJuan Feng
Juan Feng
Streptococcus agalactiae is an important pathogen of tilapia causing enormous economic losses worldwide. In this study, multilocus sequence typing indicated that 75 S. agalactiae isolates from tilapia in southern China belonged to sequence type-7, as well as belonging to serotype Ia, as confirmed by multiplex PCR assay. The putative-virulence gene profiles and genetic variation of these strains were determined by three sets of multiplex PCR and multi-virulence locus sequencing typing (MVLST), respectively. Analysis of putative-virulence gene profiles showed that each strain harbored 18 putative-virulence genes but lacked lmb and scpB. Three putative-virulence genes (srr-1, bibA and fbsA) were further selected for MVLST analysis. Our data showed that the strains had 14 MVLST types (1–14) and clustered in three groups (Groups I–Ⅲ). The period of time during 2013 and 2014 was an important turning point for the differentiation of the putative-virulence genes of S. agalactiae, as type 1 within Group Ⅱ became the predominant MVLST type. There were significant differences in MVLST types of S. agalactiae isolated from different tilapia farming regions. MVLST assay may improve the discriminatory power and is suitable for understanding the epidemiology of S. agalactiae serotype Ia and screening multivalent vaccine candidate strains.

16 September 2020 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
CZChanjuan Zhang
Chanjuan Zhang
Neng ZhuNeng Zhu
Neng Zhu
CLChan Liu
Chan Liu
HWHongtao Wu
Hongtao Wu
YYYantao Yin
Yantao Yin
LQLi Qin
Li Qin
Renal cell carcinoma (RCC) has a high mortality rate among urological malignancies, and its underlying mechanisms remain unclear. Steroid receptor RNA coactivator (SRA) belongs to the long non‑coding RNAs (lncRNAs) and has been demonstrated to be closely related to various types of cancer. In the present study, the decreased expression level of SRA was first confirmed in RCC tissues and cell lines by RT‑qPCR. Using knockdown or overexpression systems, it was then found that SRA inhibited the proliferation of RCC cell lines and promoted their apoptosis. In addition, SRA suppressed the migration and invasion, and altered EMT‑related markers in RCC cells. More importantly, it was demonstrated that SRA reduced percentage of CD44+/CD24‑ cells and the sphere‑forming efficiency. SRA also attenuated the expression levels of CD44, SOX‑2, ABCG2 and OCT‑4, which are all associated with cancer cell stemness characteristics. Although SRA increased the phosphorylation of extracellular‑regulated protein kinase (ERK), the ERK1/2 pathway could not further interfere with the alteration of EMT‑related markers mediated by SRA. Notably, the ERK inhibitor, PD98059, abolished ERK1/2 phosphorylation, whereas it did not exert any marked effects on cell proliferation and EMT‑related markers mediated by SRA. Taken together, the findings of the present study indicate that SRA is an important molecule that inhibits the migration, invasion and stem cell characteristics of RCC cells; the ERK signaling pathway may not be involved in this process.

1 November 2023 in Journal of Holistic Integrative Pharmacy
Verified
Journal Article
Open access
SLShuai Li
Shuai Li
CLChan Liu
Chan Liu

1 September 2016 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
LQLi Qin
Li Qin
CLChan Liu
Chan Liu
YNYa-Guang Ni
Ya-Guang Ni
YSYa-Ning Shi
Ya-Ning Shi
BABao-Xue Ao
Bao-Xue Ao
DLDuan-Fang Liao
Duan-Fang Liao
Hypertension is closely associated with profound vascular remodeling, especially proliferation and hyperplasia of vascular smooth muscle cells (VSMCs). Aberrant Wnt5a signaling has been related to vascular diseases, but its role on the proliferation of VSMCs is unclear. The study evaluated the effect of Wnt5a on the proliferation of VSMCs and its possible mechanism. The capability of cell proliferation was detected by the assays of MTT, colony formation and EdU cell proliferation. Flow cytometry detections were applied to evaluate the cell cycle. The expressions of specific proteins were detected by western blotting. Immunofluorescence analysis was utilized to observe the localization of Wnt5a and Ror2. The data show that serum induced proliferation of VSMC in a time-dependent manner, accompanied with a significant decrease of Wnt5a expression. Treatment with recombinant mouse Wnt5a or overexpression of Wnt5a leads to the proliferative inhibition of VSMCs and cell cycle arrest at G0/G1 phase, which related to the down-regulation of CyclinD1 and up-regulation of p53. Whereas knockdown of Wnt5a has an opposite effect. Both of Wnt5a and Ror2 are co-localized in the membrane surface. Additionally, knockdown of Ror2 decreases Wnt5a expression and the phenotype of cell proliferation induced by Wnt5a overexpression are rescued. Moreover, Wnt5a promotes Ror2 expression, which has been shown to specifically interact with the non-canonical Wnt signaling pathway. Therefore, protein kinase C (PKC) signaling was activated by Wnt5a in VSMCs, which was also accompanied with upregulation of p53 and reduction of CyclinD1. A positive feedback loop between Wnt5a and phospho-PKC to regulate CyclinD1 expression was also revealed. Furthermore, knockdown of p53 dramatically increases CyclinD1 expression. Taken together, Wnt5a exerts its beneficial effects on VSMCs proliferation and vascular remodeling. Wnt5a/Ror2/PKC signaling pathway is involved in suppression of VSMC proliferation by down-regulating and up-regulating the expression of CyclinD1 and p53 respectively.

27 November 2024 in Asian Journal of Surgery
Verified
Journal Article
Open access
NHNan Huang
Nan Huang
XLXiang Liu
Xiang Liu
CLChan Liu
Chan Liu
ZLZheng Liu
Zheng Liu